Clinical Trials Directory

Trials / Completed

CompletedNCT04412798

Orange Juice and Glycaemic Control in Type 2 Diabetes Mellitus

Impact of Orange Juice During Breakfast on Glycaemic Control in Individuals With Type 2 Diabetes Mellitus

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Hasselt University · Academic / Other
Sex
All
Age
25 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The evidence on the consumption of 100% orange juice in people with type 2 diabetes is highly variable and largely out-of-date, with a few studies reporting acute negative glycaemic effects when 100% orange juice is drunk with or without a meal. The aim of the project is to study the impact of the intake of a single serving of 100% orange juice on glycaemic control in male patients with pre-existing type 2 diabetes mellitus. In addition, immunological parameters and Alzheimer disease related biomarkers will be assessed to examine the chronic inflammatory state of these patients

Conditions

Interventions

TypeNameDescription
OTHERorange juice concentrate250mL of 100% orange juice made from concentrate
OTHERSugar-sweetened orange-flavoured beverageSugar-sweetened orange-flavoured beverage, energy-matched to the orange juice condition
OTHERWhole orange juice with skin removedWhole orange pieces with skin removed, energy-matched to the orange juice condition

Timeline

Start date
2020-05-01
Primary completion
2024-04-01
Completion
2024-04-01
First posted
2020-06-02
Last updated
2024-05-17

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04412798. Inclusion in this directory is not an endorsement.